highly significantp = 0.006
Thus, when comparing anatomical locations, in the cervix 2.0% of the HPV16 samples had a mutation in the E6 gene versus 18.5% in the oropharynx, demonstrating a highly significant difference (p = 0.006).
Thus, when comparing anatomical locations, in the cervix 2.0% of the HPV16 samples had a mutation in the E6 gene versus 18.5% in the oropharynx, demonstrating a highly significant difference (p = 0.006).
A trend for higher HPV35 prevalence in oropharynx was also identified, but did not reach statistical significance.
HPV prevalence in oropharyngeal cancers showed an increasing trend from 60% in 2003 to 80% in 2016.